BALYASNY ASSET MANAGEMENT L.P. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$80,585
+41.4%
90,954
+152.0%
0.00%
Q3 2022$57,000
-54.0%
36,094
-41.3%
0.00%
Q2 2022$124,000
+93.8%
61,446
+345.1%
0.00%
Q4 2021$64,000
-49.2%
13,805
-9.6%
0.00%
-100.0%
Q1 2021$126,000
-12.5%
15,266
-27.8%
0.00%0.0%
Q4 2020$144,000
-68.3%
21,130
-79.5%
0.00%
-50.0%
Q3 2018$454,000103,2520.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders